XML 118 R90.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidation - Revenue and Expenses of Consolidated Investment Product (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income:                      
Total revenues $ 146,084 $ 145,955 $ 140,489 $ 130,718 $ 138,065 $ 152,210 $ 132,932 $ 129,028      
Expenses:                      
Net Income (Loss) Attributable to Common Stockholders $ 20,808 $ 22,000 $ 24,842 $ 19,662 $ 77 $ 24,913 $ 20,986 $ 21,216 $ 87,312 $ 67,192 $ 28,676
CLOs                      
Income:                      
Realized and unrealized gain (loss), net                 (8,914)    
Interest Income                 113,053    
Total revenues                 104,139    
Expenses:                      
Other operating expenses                 3,367    
Interest expense                 92,005    
Total Expense                 95,372    
Noncontrolling interests                 1,028    
Net Income (Loss) Attributable to Common Stockholders                 $ 9,795